SPRC — Scisparc Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $3.13m
- $1.58m
- $1.31m
Annual income statement for Scisparc, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 1.35 | 2.88 | 1.31 |
Cost of Revenue | |||||
Gross Profit | — | — | 1.02 | 2.2 | 0.506 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.29 | 5.77 | 9.63 | 9.69 | 8.62 |
Operating Profit | -3.29 | -5.77 | -8.29 | -6.82 | -7.32 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.54 | -5.79 | -2.58 | -5.86 | -7.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.54 | -5.79 | -2.59 | -5.88 | -7.47 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.48 | -5.79 | -2.59 | -5.12 | -6.28 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.48 | -5.79 | -2.59 | -5.12 | -6.28 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.05 | -73.6 | -14.8 | -10.9 | -0.929 |